Phong Phu Pharmaceutical JSC
VN:PPP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.1), the stock would be worth ₫18 100 (2% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.2 | ₫18 400 |
0%
|
| 3-Year Average | 1.1 | ₫18 100 |
-2%
|
| 5-Year Average | 1.1 | ₫17 025.94 |
-7%
|
| Industry Average | 2.2 | ₫35 371.71 |
+92%
|
| Country Average | 1.7 | ₫26 603.27 |
+45%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| VN |
P
|
Phong Phu Pharmaceutical JSC
VN:PPP
|
161.9B VND | 1.2 | 8.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
835.2B USD | 31.5 | 40.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.8B USD | 6.7 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 7.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 5.9 | 28.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.2B CHF | 5.9 | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.9B USD | 5.3 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -58.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 6 | 11.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 1.8 | 19.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.2B USD | 6.4 | 16.8 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 1.3 |
| Median | 1.7 |
| 70th Percentile | 2.2 |
| Max | 16.4 |
Other Multiples
Phong Phu Pharmaceutical JSC
Glance View
Phong Phu Pharmaceutical JSC engages in the pharmaceutical industry business. The company is headquartered in Ho Chi Minh, Ho Chi Minh. The company went IPO on 2011-07-18. The firm manufactures, imports and trades pharmaceutical products. Its pharmaceutical manufacturing factory is located at Binh Tan District, Ho Chi Minh City. The company also has a pharmaceutical manufacturing workshop located at District 8, Ho Chi Minh City. The firm is also involved in the manufacturing and trading of milk and its derived products, as well as bread, cake, chocolate, sweets, jam, pasta, noodles, tea, drinking water and non-alcoholic beverages. In addition, it manufactures functional food and trades cosmetic products. The firm is engaged in the provision of trucking services, bus services and car rental services as well.
